Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus: A report of three cases

Dermatology

Volumn 207, Issue 4, 2003, Pages 381-385

  Böhm, Markus ^a   Gaubitz, Markus ^a   Luger, Thomas A ^a   Metze, Dieter ^a   Bonsmann, Gisela ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cutaneous lupus erythematosus; FK506; Topical tacrolimus

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; HYDROXYCHLOROQUINE; ISOTRETINOIN; METHOTREXATE; PREDNISOLONE; STEROID; SUNSCREEN; TACROLIMUS;

ADULT; ARTICLE; BURNING SENSATION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; PRURITUS; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; PILOT PROJECTS; TACROLIMUS;

EID: 0344737919     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074119     Document Type: Article

References (14)

1. Patel P, Werth V: Cutaneous lupus erythematosus: A review. Dermatol Clin 2002;20:373-385.
2. Hill CJH, Rostenberg A: Adverse effects from topical steroids. Cutis 1978;21:624-628.
3. Kawakami T, Soma Y, Morita E, Koro O, Yamamoto S, Nakamura K, Tamaki K, Yajima K, Imaizumi A, Matsunaga R, Murakami N, Kashima M, Mizoguchi M: Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation. Dermatology 2001;203:32-37.
4. Bornhövd E, Burgdorf WHC, Wollenberg A: Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. J Am Acad Dermatol 2001;45:736-743.
5. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, Ahmed I, Thestrup-Pedersen K, Daniel F, Finzi A, Reitamo S: A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997;337:816-821.
6. Remitz A, Reitamo S, Erkko P, Granlund H, Lauerma AI: Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol 1999;141:103-107.
7. Choi CJ, Nghiem P: Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease. Arch Dermatol 2001,137:1202-1205.
8. Rozycki TW, Rogers RS 3rd, Pittelkow MR, Pittelkow MR, McEvoy MT, El-Azhary RA, Bruce AJ, Fiore JP, Davis MD: Topical tacrolimus in the treatment of symptomatic oral lichen planus: A series of 13 patients. J Am Acad Dermatol 2002;46:27-34.
9. Böhm M, Frieling U, Luger TA, Bonsmann G: Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003;139:922-924.
10. Yoshimasu T, Ohtani T, Sakamoto T, Oshima A, Furukawa F: Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002;12:50-52.
11. Walker SL, Kirby B, Chalmers RJG: The effects of tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 2002;147:385-410.
12. Kanekura T, Yoshii N, Terasaki K, Miyoshi H, Kanzaki T: Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol 2003;148:353-346.
13. Reitamo S, Rissanen J, Remitz A, Granlund H, Erkko P, Elg P, Autio P, Lauerma AI: Tacrolimus ointment does not affect collagen synthesis: Results of a single-center randomized trial. J Invest Dermatol 1998;111:396-398.
14. Kikuchi K, Tagami H: Comparison of the effects of daily applications between topical corticosteroids and tacrolimus ointments on normal skin: Evaluation with noninvasive methods. Dermatology 2002;205:378-382.